- Search results for 778270-11-4
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
3 products were found matching "778270-11-4"!
Close filters
Filter by:
No results were found for the filter!
Item number: TGM-T1817-100mg
Description: GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl. Target: SARS-CoV, Bcr-Abl. Smiles: NC(=O)c1cccc(c1)-c1cc(Nc2ccc(OC(F)(F)F)cc2)ncn1. References: Adrián FJ, et al. Nat Chem Biol, 2006, 2(2), 95-102
Keywords: | GNF2 |
Application: | Bcr-abl inhibitor |
CAS | 778270-11-4 |
MW: | 374.32 D |
From 31.00€
*
Item number: Cay16253-1
GNF-2 is an allosteric inhibitor of Bcr-Abl (IC50 = 267 nM). It is selective for Bcr-Abl over c-Abl and a panel of 63 additional kinases at 10 µM. It inhibits proliferation of Ba/F3 cells (IC50 = 138 nM). GNF-2 (10 µM) reduces viral titers in Vero cells infected with infectious bronchitis virus (IBV), a coronavirus,...
Keywords: | Bcr-Abl Inhibitor, 3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]-benzamide |
Application: | Bcr-abl inhibitor |
CAS | 778270-11-4 |
MW: | 374.3 D |
From 125.00€
*
Item number: LKT-G5320.1
GNF-2 is an inhibitor of Abl kinase that exhibits anticancer chemotherapeutic, anti-resorptive, and anti-osteoporotic activities. GNF-2 shows potential benefit in the treatment of Philadelphia chromosome-positive acute myelogenous leukemia (ALL). In vitro, GNF-2 inhibits differentiation of osteoclasts, activity of...
Application: | Bcr-abl inhibitor |
CAS | 778270-11-4 |
MW: | 374.32 D |
From 149.00€
*